Latin America set for 10% average pharma growth, Deutsche Bank predicts
This article was originally published in Scrip
Executive Summary
When the pharmaceutical industry talks about emerging markets, the emphasis is on Asia and especially China, but Latin America also has an attractive growth rate, says one major investment bank.